Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited12.29366256349997.4497
Domestic EquitiesLupin Limited7.26493083991589.4432
Domestic EquitiesDivi's Laboratories Limited7.01251000031568.9676
Domestic EquitiesCipla Limited6.47573495054525.4115
Domestic EquitiesApollo Hospitals Enterprise Limited5.9245648795480.6922
Domestic EquitiesDr. Reddy's Laboratories Limited5.90633916074479.2100
Domestic EquitiesVijaya Diagnostic Centre Limited3.55782886684288.6684
Domestic EquitiesMedPlus Health Services Limited3.38633627277274.7481
Domestic EquitiesGland Pharma Limited3.24151320549263.0005
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.9936913226242.8907
Domestic EquitiesAjanta Pharma Limited2.8451959323230.8419
Domestic EquitiesSai Life Sciences Limited2.71122555745219.9730
Domestic EquitiesAbbott India Limited2.479268677201.1549
Domestic EquitiesDr. Lal Path Labs Limited2.3409609112189.9272
Domestic EquitiesAurobindo Pharma Limited2.27461702630184.5481
Domestic EquitiesMankind Pharma Limited2.2740757496184.5033
Domestic EquitiesThyrocare Technologies Limited2.24981572828182.5424
Domestic EquitiesNarayana Hrudayalaya Limited2.20421029215178.8364
Domestic EquitiesAlkem Laboratories Limited2.1642323678175.5953
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.1065999649170.9100
Domestic EquitiesBiocon Limited1.98354719374160.9307
Domestic EquitiesPfizer Limited1.9753318249160.2702
Domestic EquitiesSuraksha Diagnostic Limited1.43283896349116.2476
Domestic EquitiesIPCA Laboratories Limited1.3533820020109.8007
Domestic EquitiesTorrent Pharmaceuticals Limited1.3472303364109.3081
Domestic EquitiesSanofi India Limited1.3197230272107.0765
Domestic EquitiesFortis Healthcare Limited1.31951103889107.0552
Domestic EquitiesSanofi Consumer Healthcare India Limited1.2431213659100.8577
Domestic EquitiesAnthem Biosciences Limited0.9931105850380.5732
Domestic EquitiesSyngene International Limited0.9830128049279.7554
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8244151526466.8913
Domestic EquitiesEmcure Pharmaceuticals Limited0.741847027260.1901
Domestic EquitiesAstraZeneca Pharma India Limited0.70226256856.9713
Domestic EquitiesIndoco Remedies Limited0.6603183492453.5706
Domestic EquitiesOrchid Pharma Limited0.426349272734.5894
Domestic EquitiesZydus Lifesciences Limited0.234819401619.0504
Domestic EquitiesConcord Biotech Limited0.226911173818.4111
Total 99.4734 8070.8639
Cash & Cash Equivalents and Net AssetsTriparty Repo0.4624 37.5168
Cash & Cash Equivalents and Net AssetsNet Current Assets0.0616 4.9981
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0026 0.2145
Total 0.5266 42.7294
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.